Free Trial

Corbus Pharmaceuticals (CRBP) Institutional Ownership

Corbus Pharmaceuticals logo
$7.38 -0.16 (-2.12%)
Closing price 06/3/2026 04:00 PM Eastern
Extended Trading
$7.49 +0.11 (+1.49%)
As of 07:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Corbus Pharmaceuticals (NASDAQ:CRBP)

Current
Institutional Ownership
Percentage
64.64%
Number of
Institutional Buyers
(last 12 months)
40
Total
Institutional Inflows
(last 12 months)
$39.23M
Number of
Institutional Sellers
(last 12 months)
21
Total
Institutional Outflows
(last 12 months)
$11.00M
Get CRBP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corbus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CRBP Institutional Buying and Selling by Quarter

Corbus Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE13,960$131K0.0%+53,592.3%0.075%
5/18/2026 Royal Bank of Canada29,901$281K0.0%+81.2%0.161%
5/18/2026 Exome Asset Management LLC234,136$2.20M1.1%+67.8%1.264%
5/16/2026 Orbimed Advisors LLC1,737,287$16.31M0.3%+8.8%9.376%
5/15/2026 Rangeley Capital LLC44,840$421K0.4%N/A0.242%
5/15/2026 OMERS ADMINISTRATION Corp15,200$143K0.0%-49.3%0.082%
5/14/2026 Renaissance Technologies LLC346,998$3.26M0.0%-2.1%1.873%
5/14/2026 Pale Fire Capital SE21,350$200K0.0%+14.5%0.115%
5/7/2026 Dimensional Fund Advisors LP136,602$1.28M0.0%+76.6%0.770%
4/20/2026 Assenagon Asset Management S.A.85,246$800K0.0%-54.6%0.481%
2/26/2026 Seven Fleet Capital Management LP56,750$462K0.4%N/A0.323%
2/23/2026 Virtu Financial LLC10,760$88K0.0%N/A0.061%
2/18/2026 Quadrature Capital Ltd29,889$243K0.0%N/A0.170%
2/18/2026 Orbimed Advisors LLC1,597,287$13.00M0.3%+36.3%9.100%
2/18/2026 Millennium Management LLC37,065$302K0.0%-72.8%0.211%
2/18/2026 Engineers Gate Manager LP17,143$140K0.0%N/A0.098%
2/18/2026 Caption Management LLC56,066$456K0.0%-170.1%0.319%
2/18/2026 Cormorant Asset Management LP2,344,971$19.09M0.9%-1.3%13.359%
2/18/2026 Balyasny Asset Management L.P.133,311$1.09M0.0%+469.3%0.759%
2/18/2026 Armistice Capital LLC536,000$4.36M0.1%+179.2%3.054%
2/18/2026 683 Capital Management LLC85,543$696K0.0%N/A0.487%
2/17/2026 ADAR1 Capital Management LLC286,781$2.33M0.2%+2,711.6%1.634%
2/17/2026 Trexquant Investment LP27,275$222K0.0%+124.2%0.155%
2/17/2026 Jump Financial LLC60,300$491K0.0%N/A0.344%
2/17/2026 Laurion Capital Management LP18,600$151K0.0%N/A0.106%
2/17/2026 Persistent Asset Partners Ltd6,587$54K0.0%N/A0.038%
2/16/2026 OMERS ADMINISTRATION Corp30,000$244K0.0%N/A0.171%
2/16/2026 Mariner LLC17,086$139K0.0%-18.0%0.097%
2/16/2026 Barclays PLC14,758$120K0.0%+280.0%0.084%
2/13/2026 Prosight Management LP683,872$5.57M1.2%+99.1%3.897%
2/13/2026 Marshall Wace LLP77,546$631K0.0%-24.4%0.442%
2/13/2026 Hudson Bay Capital Management LP17,089$139K0.0%N/A0.097%
2/13/2026 Exome Asset Management LLC139,543$1.14M0.5%-39.3%0.795%
2/13/2026 Velan Capital Investment Management LP13,000$106K0.1%-78.7%0.074%
2/12/2026 Jane Street Group LLC28,064$228K0.0%-51.7%0.160%
2/12/2026 Renaissance Technologies LLC354,300$2.88M0.0%+230.5%2.019%
2/12/2026 Dimensional Fund Advisors LP77,354$630K0.0%N/A0.441%
2/10/2026 Goldman Sachs Group Inc.47,438$386K0.0%+42.2%0.270%
2/10/2026 BRC Group Holdings Inc.38,714$315K0.1%N/A0.221%
2/9/2026 Geode Capital Management LLC170,873$1.39M0.0%+33.8%0.974%
9 days. (Ad)

SpaceX is set to price on June 12 in what could be the largest IPO in history at a $1.75 trillion valuation. Before that happens, analyst Dylan Jovine says there's one small, publicly traded company that Musk's entire empire depends on - and it's still dirt cheap. Once the S-1 hits and every fund and financial journalist starts digging, this window closes. Jovine is releasing the name and ticker today.tc pixel

See the ticker tied to SpaceX before the June 12 window closes
2/6/2026 Atle Fund Management AB107,255$873K0.3%-38.9%0.611%
1/16/2026 Aberdeen Group plc1,321,750$10.76M0.0%+602.2%7.531%
1/12/2026 Avanza Fonder AB4,868$40K0.0%-31.9%0.028%
1/9/2026 Assenagon Asset Management S.A.187,956$1.53M0.0%+120.2%1.071%
11/17/2025 Velan Capital Investment Management LP61,000$772K0.7%+3.4%0.498%
11/17/2025 Prelude Capital Management LLC66,984$847K0.1%-16.6%0.547%
11/17/2025 Mariner LLC20,840$264K0.0%+34.0%0.170%
11/17/2025 Millennium Management LLC136,429$1.73M0.0%-14.3%1.113%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.85,826$1.09M0.0%-27.9%0.700%
11/17/2025 HighVista Strategies LLC118,027$1.49M0.4%+56.8%0.963%
11/17/2025 Bank of America Corp DE54,661$691K0.0%-24.0%0.446%
11/17/2025 Ameriprise Financial Inc.69,625$881K0.0%N/A0.568%
11/14/2025 ADAR1 Capital Management LLC10,200$129K0.0%N/A0.083%
11/14/2025 Two Sigma Investments LP26,457$335K0.0%-41.9%0.216%
11/14/2025 Prosight Management LP343,400$4.34M1.0%-40.8%2.802%
11/13/2025 UBS Group AG59,496$753K0.0%-35.2%0.485%
11/7/2025Vanguard Group Inc.612,030$7.74M0.0%+2.1%4.994%
11/7/2025 Aberdeen Group plc188,231$2.38M0.0%+160.6%1.536%
11/3/2025 AlphaQuest LLC18,994$240K0.0%-39.8%0.155%
10/7/2025 Assenagon Asset Management S.A.85,347$1.08M0.0%N/A0.696%
8/15/2025 Exome Asset Management LLC277,317$1.91M1.0%-4.3%2.262%
8/15/2025 Bank of America Corp DE71,893$496K0.0%+333.6%0.586%
8/14/2025 Jane Street Group LLC18,878$130K0.0%-13.6%0.154%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.119,056$821K0.0%-7.7%0.971%
8/14/2025 Armistice Capital LLC192,000$1.33M0.0%-23.2%1.566%
8/14/2025 Baker Avenue Asset Management LP20,000$138K0.0%N/A0.163%
8/13/2025 Marshall Wace LLP19,871$137K0.0%N/A0.162%
8/8/2025 Geode Capital Management LLC134,091$926K0.0%-50.6%1.094%
8/5/2025Corton Capital Inc.12,516$86K0.1%N/A0.102%
8/1/2025 Y Intercept Hong Kong Ltd20,437$141K0.0%N/A0.167%
7/31/2025 AlphaQuest LLC31,536$218K0.0%-44.1%0.258%
7/24/2025 Aberdeen Group plc72,226$498K0.0%+168.6%0.590%
7/14/2025 Atle Fund Management AB175,582$1.21M0.5%+78.6%1.434%
5/21/2025Acadian Asset Management LLC190,093$1.01M0.0%N/A1.553%
5/19/2025Jane Street Group LLC21,861$116K0.0%-95.5%0.179%
5/16/2025Exome Asset Management LLC289,690$1.54M1.3%N/A2.367%
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.129,043$685K0.0%-20.8%1.055%
5/16/2025AQR Capital Management LLC107,983$573K0.0%N/A0.882%
5/15/2025Armistice Capital LLC250,000$1.33M0.0%+5.9%2.043%
5/15/2025Velan Capital Investment Management LP59,000$313K0.3%+4.1%0.482%
5/14/2025Comerica Bank200,001$1.06M0.0%+20,000,000.0%1.634%
5/14/2025Stonepine Capital Management LLC35,000$186K0.2%N/A0.286%
5/14/2025AlphaQuest LLC56,390$299K0.0%N/A0.461%
5/12/2025Nuveen LLC45,689$243K0.0%N/A0.374%
5/9/2025Charles Schwab Investment Management Inc.88,525$470K0.0%-9.6%0.724%
2/17/2025Velan Capital Investment Management LP56,700$669K0.6%+13.4%0.466%
2/17/2025Wexford Capital LP45,021$531K0.1%-34.3%0.370%
2/17/2025Two Sigma Advisers LP11,027$130K0.0%N/A0.091%
2/17/2025Two Sigma Investments LP134,175$1.58M0.0%+212.3%1.102%
2/17/2025Tang Capital Management LLC242,653$2.86M0.2%-59.6%1.992%
Trump’s New Dollar revealed (Ad)

The last time something like this happened was 1974 - a secret deal that quietly determined the financial fate of an entire generation. According to Porter Stansberry, founder of one of the largest independent financial research firms in the world, it is happening again. Fortune calls it 'the biggest change to the world's relationship with the dollar' in a generation. Stansberry says Trump's money reset - enacted through executive orders and a treaty signed by 13 nations in December 2025 called Pax Silica - could determine whether you are enriched or quietly impoverished by the shift already underway.tc pixel

Read Porter Stansberry's full briefing and find out which moves to make now
2/17/2025Prosight Management LP270,000$3.19M0.9%+107.7%2.217%
2/17/2025Nuveen Asset Management LLC28,938$341K0.0%-77.8%0.238%
2/17/2025Orbimed Advisors LLC1,172,287$13.83M0.3%+28.5%9.625%
2/17/2025Millennium Management LLC386,653$4.56M0.0%+215.0%3.174%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.162,962$1.92M0.0%-5.6%1.338%
2/17/2025Deutsche Bank AG8,206$97K0.0%+46.8%0.067%
2/17/2025Bank of America Corp DE31,475$371K0.0%+29.7%0.258%
2/17/2025BNP Paribas Financial Markets27,383$323K0.0%N/A0.225%
2/14/2025Northern Trust Corp103,264$1.22M0.0%+12.4%0.848%
2/14/2025Aquatic Capital Management LLC8,555$101K0.0%N/A0.070%


CRBP Institutional Ownership - Frequently Asked Questions

During the previous two years, 89 institutional investors and hedge funds held shares of Corbus Pharmaceuticals. The most heavily invested institutionals were Cormorant Asset Management LP ($19.09M), Orbimed Advisors LLC ($16.31M), Darwin Global Management Ltd. ($14.27M), State Street Corp ($12.29M), Aberdeen Group plc ($10.76M), Point72 Asset Management L.P. ($9.80M), and Vanguard Group Inc. ($7.74M).Learn more on Corbus Pharmaceuticals' institutional investors.

64.64% of Corbus Pharmaceuticals' stock is owned by institutional investors. Learn more on CRBP's institutional investor holdings.

Of the 76 institutional investors that purchased Corbus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Aberdeen Group plc ($1.29M), Orbimed Advisors LLC ($824.74K), Prosight Management LP ($480.47K), Exome Asset Management LLC ($384.28K), Renaissance Technologies LLC ($370.20K), Armistice Capital LLC ($358K), and Darwin Global Management Ltd. ($325.14K).

Institutional investors have bought a total of 4,610,381 shares in the last 24 months. This purchase volume represents approximately $39.23M in transactions.

Of the 21 institutional investors that sold Corbus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Prosight Management LP ($236.49K), Geode Capital Management LLC ($137.42K), Millennium Management LLC ($122.10K), Exome Asset Management LLC ($102.79K), Assenagon Asset Management S.A. ($102.71K), Atle Fund Management AB ($68.33K), and Armistice Capital LLC ($58K).

Institutional investors have sold a total of 1,154,641 shares in the last 24 months. This volume of shares sold represents approximately $11.00M in transactions.



This page (NASDAQ:CRBP) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners